Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients

Published:1995-11 Issue:6 Volume:19 Page:784-789
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J. Surg.

Author:

Tang Zhao-You,Yu Ye-Qin,Zhou Xin-Da,MA Zeng-Chen,Lu Ji-Zheu,Lin Zhi-Ying,Liu Kang-Da,Ye Sheng-Long,Yang Bing-Hui,Wang Hong-Wei,Sun Hui-Chuan

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/BF00299771.pdf

Reference40 articles.

1. Wingo, P.A., Tong, T, Bolden, S.: Cancer statistics, 1995. Ca. Cancer J. Clin. 45:8, 1995

2. Rusch, V.W., Albain, K.S., Crowley, J.J., et al.: Surgical resection of stage IIIA and stage IIIB non-small cell lung cancer after concurrent induction chemoradiortherapy. A Southwest Oncology Group trial. J. Thorac. Cardiovasc. Surg. 105:97, 1993

3. Reynolds, M., Douglass, E.C., Finegold, M., Cantor, A., Glicksman, A.: Chemotherapy can convert unresectable hepatoblastoma. J. Pediatr. Surg. 27:1080, 1992

4. Sitzmann, J.V., Order, S.E., Klein, J.L., Leichner, P.K., Fishman, E.K., Smith, G.W.: Conversion by new treatment modalities of unresectable to resectable hepatocellular carcinoma. J. Clin. Oncol. 5:1566, 1987

5. Sitzmann, J.V., Abrams, R.: Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann. Surg. 217:149, 1993

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody;The Oncologist;2024-03-13

2. Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy;Journal of Hepatocellular Carcinoma;2024-03

3. Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study;Journal of Cancer Research and Clinical Oncology;2023-08-17

4. Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study;Frontiers in Oncology;2022-11-24

5. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition);Hepatobiliary Surgery and Nutrition;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3